Global Genetic Engineering Market is expected to reach USD 6.90 billion by 2023 at a CAGR of 12.48% during forecast period 2017 to 2023.
Top Key Players:
Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), and Horizon Discovery Group Plc. (U.K.). The other players of the market are Transposagen Biopharmaceuticals Inc. (U.S.)., New England Biolabs (U.S), Genscript Biotech Corporation (U.S.), Lonza Group Ltd. (Switzerland), Inc. (U.S.), Origene Technologies, Inc. (U.S.), and Integrated DNA Technologies, Inc (U.S.)
Get Premium Sample Copy @ https://www.marketresearchfuture.com/sample_request/1528
Global Genetic Engineering Market – Overview:
The market is forecasted to demonstrate a double digit growth by 2027, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period 2017 – 2027.
The Genetic Engineering Market is expected to grow at a rapid pace. The factors influencing the growth of the market include increasing technologies for gene, widespread use of genetic engineering found in developed countries, special attention towards stem cells, increasing use of genetic engineering in medicine and various others.
Technology advanced products helps in treatment of various diseases. Organisms are also used for insulin production required for the treatment of patients suffering from diabetes. Hence, genetic engineering is expected to be an emerging technology in the field of medicine, enhancing the growth of this market. Increasing funding for research and development of medical products is further favouring the growth of the market.
Global Genetic Engineering Market - Competitive Analysis:
Characterized by the presence of several well-established and small players, the global market of Genetic engineering appears to be highly competitive and fragmented. With well-established market in the North America region major companies like Thermo Fisher Scientific Inc, Transposagen Biopharmaceuticals Inc., New England Biolabs, Genscript Biotech Corporation, Integrated DNA Technologies, Inc and various others have their home in the region and generate maximum market share. These companies have expanded their operating unit in various other emerging regions as well. Moreover the other small and medium scale players are generating revenue from local market.
Thermo Fisher Scientific Inc. an American international biotechnology company founded in 2006 by the merger of Thermo Electronic and Fisher Scientific. In Feb 2014, the company announced the complete acquisition of Life Technology Corp for USD 76.13 Billion. Life Technology Corp is a global leading player in genetic testing and precision laboratory equipment. New instruments in genetic engineering technology are Ion S5 sequencing systems, Sanger sequencing, QuantStudio family, QuantiGene Plex Assay, QuantiGene Singleplex Assay and QuantiGene Singleplex HT Assay. This acquisition will help the company create unrivalled control in serving research, life sciences, specialty diagnostics and applied markets.
Get Attractive Discount @ https://www.marketresearchfuture.com/check-discount/1528
Merck KGaA is one of the world's leading supplier of materials and equipment in biotechnology sector. The company supplies all the equipment’s and products required in genetic engineering from bioreactors, cell lines and ultra-pure water of laboratories. To enlarge the life science division, the company in November 2015, announced the complete acquisition of Sigma-Aldrich with USD 17 billion. Merck's major research centers for medical biotechnology are located in Darmstadt (Germany), Beijing (China), Tokyo (Japan) and Boston (United States). “Centinel” technology is a combination of biologic solutions and advanced genetic editing technology. With this acquisition the company will increase its man power with 50,000 employees in more than 67 countries, working at 72 manufacturing sites worldwide.
Global Genetic Engineering Market - Regional Analysis:
Global genetic engineering market is segmented on the basis of geographies or regions which mainly includes North America, Europe, Asia Pacific, and Middle East & Africa. North America is dominating the global market for genetic engineering with more than 40% share of the total market in 2016. The major factor for the growth of the market include due to increasing use of genetic engineering in for the use of gene therapy, high incidence of cancer and neurological disorders like Alzheimer’s, dementia. Increasing awareness for the use of stem cells furthermore contribute influence the growth of market in North America.
Europe holds the second largest share of the global genetic engineering market. Asia Pacific is the fastest growing genetic engineering stimulation market across the globe. In Asia-Pacific there is wide range of opportunities for genetic engineering market due to the presence of developing countries, companies grabbing these opportunities and expanding their presence in the region. The developing countries in this region are widely adopting latest technologies in the field of genetic engineering. These rising development in the region is further influencing the growth of the market.
The Middle East & Africa holds the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.
Table of Content
2.2 Scope of the Study
2.3 Research Objective
2.6 Market Structure
2.7 Market Segmentation
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4 Market Dynamics
4.4 Mega Trends
4.5 Macroeconomic Indicators
Request for Full TOC @ https://www.marketresearchfuture.com/request-toc/1528